JP Nadda: Deliberating on Johnson & Johnson issue

Six months after an expert committee recommended that Johnson & Johnson give Rs 20 lakh as compensation to each patient affected by “faulty” hip implants sold by its subsidiary, the Union Health Ministry is yet to take a call on the matter.

By: Express News Service

New Delhi | August 28, 2018 03:33 AM IST

1 min read

Vibrant Gujarat, Vibrant Gujarat Summit, healthcare and pharmaceuticals, J P Nadda, shaping a New paradigm in Medical & Pharma Service, Indian Express

Union Health Minister J P Nadda will preside over the seminar titled ‘Shaping a New Paradigm in Medical & Pharma Services’. (Express Photo by Prem Nath Pandey/File)

Replying to a question on the committee’s report that was not made public, Health Minister J P Nadda said: “We are deliberating on the matter and will come back soon.”

The findings of the expert committee, reported in The Indian Express, constitute the first official indictment in India against J&J, which imported and sold ASR XL Acetabular Hip System and ASR Hip Resurfacing System in the country — these devices were globally recalled in 2010.

Stay updated with the latest - Click here to follow us on Instagram

Tags:

JP Nadda